Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized vs IV Dexmedetomidine or Lidocaine for Intubation Hemodynamics
NCT05941767Completed
- Sponsor
- Zagazig University
- Start
- Jul 2023
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine and Lidocaine Hydrochloride Injection, without epinephrine in hemodynamic instability (4 arms), sponsored by Zagazig University. Primary endpoints: Change in serum cortisol levels, Change in mean arterial blood pressure and 3 more. Started Jul 2023; status: completed.
02
Drugs
dexmedetomidineLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT05941767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05941767.